TABLE 3.
Antibody avidity indices of sera from individual monkeys immunized with combinations of the DENV-2 DNA, PIV, and recombinant vaccinesa
| Vaccination group | Monkey | Antibody avidity indexb
|
||
|---|---|---|---|---|
| Day 90 | Day 210 challenge | Day 28 postchallenge | ||
| DRR | 942 | 19 | 25 | 26 |
| 898 | 16 | 39 | 63 | |
| WTV | 39 | 49 | 33 | |
| XJX | 33 | 31 | 40 | |
| GMT | 25 | 35 | 38 | |
| DPP | 992 | 27 | 53 | 57 |
| VFE | 33 | 43 | 80 | |
| VAP | 26 | 50 | 42 | |
| XCW | 33 | 57 | 73 | |
| GMT | 30 | 50 | 61 | |
| DR/DR/DR | A25 | 19 | 31 | 52 |
| 939 | 30 | 40 | 60 | |
| 981 | 26 | 28 | 38 | |
| 973 | 20 | 56 | 50 | |
| GMT | 23 | 37 | 50 | |
| DP/DP/DP | 975 | 19 | 33 | 55 |
| 895 | 41 | 53 | 52 | |
| 921 | 33 | 35 | 55 | |
| JWK | 45 | 37 | 47 | |
| GMT | 33 | 39 | 52 | |
| RRR | 999 | 17 | 43 | 28 |
| C67 | 12 | 36 | 27 | |
| C51 | 13 | 30 | 29 | |
| B27 | 15 | 17 | 32 | |
| GMT | 14 | 30 | 29 | |
| PPP | A79 | 22 | 59 | 62 |
| A43 | 40 | 63 | 85 | |
| A65 | 47 | 68 | 64 | |
| C49 | 33 | 67 | 91 | |
| GMT | 34 | 64 | 75 | |
| DDD | 931 | 30 | 33 | 55 |
| GZ | 25 | 47 | 53 | |
| F483 | 29 | 45 | 43 | |
| 28R | 40 | 40 | 39 | |
| GMT | 30 | 41 | 47 | |
| PBS | 887 | —c | — | 3 |
| CO7 | — | — | 6 | |
| 923 | — | — | 6 | |
| B13 | — | — | 5 | |
| GMT | 5 | |||
D, DNA vaccine; P, PIV; R, recombinant vaccine.
Avidity index = (OD405 after NASCN treatment)/(OD405 without NASCN treatment) × 100.
—, no DEN-specific antibody was detectable.